CIC
CELG

Chase Investment Counsel’s Celgene Corp CELG Stock Holding History

Chase Investment Counsel’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-38,140
Closed -$5.56M – 91
2017
Q3 		$5.56M Sell
38,140
-5,737
-13% -$781K 2.92% 8
2017
Q2 		$5.7M Sell
43,877
-2,069
-5% -$254K 2.77% 10
2017
Q1 		$5.72M Buy
45,946
+9,944
+28% +$1.19M 2.75% 10
2016
Q4 		$4.17M Buy
+36,002
New +$4.01M 2.07% 18

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Chase Investment Counsel's CELG Position: Q4 2017 in Review

Chase Investment Counsel sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 38,140 shares — an estimated $5.56M sold.

Chase Investment Counsel first reported a position in CELG in Q4 2016 and held it in 4 quarters. The position peaked at $5.72M in Q1 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Chase Investment Counsel reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Chase Investment Counsel sold 38,140 Celgene Corp shares in Q4 2017, an estimated $5.56M.
  • Chase Investment Counsel first reported a position in Celgene Corp in Q4 2016 and held it in 4 quarters.
  • Chase Investment Counsel's Celgene Corp position peaked at $5.72M in Q1 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Chase Investment Counsel's 13F filing for Q4 2017, filed 5 Feb 2018.